Popular weight loss drug could cause sudden blindness – EU’s health watchdog
The producer of Ozempic was advised to list the serious eye condition as a side effect The European Medicines Agency (EMA) has concluded that semaglutide-based medications – including Ozempic, Wegovy, and Rybelsus – increase the risk of a serious eye condition that can lead to sudden vision loss. Following a comprehensive safety review, the EMA’s […]
GLP-1 Drugs Linked to Age-Related Macular Degeneration, Study Finds
GLP-1 drugs like Ozempic could lead to a higher risk of wet age-related macular degeneration in people with type 2 diabetes. Westend61/Getty Images GLP-1 drugs are associated with a higher risk of “wet” age-related macular degeneration in people with type 2 diabetes, according to a new study. Researchers found that the risk substantially increased the […]
EMA warns Ozempic linked to ‘very rare’ side effect
The EMA’s safety committee has issued a warning that the GLP-1 receptor agonist Ozempic (semaglutide, Novo Nordisk A/S) can cause an acute eye condition in which the optic nerve is damaged by a sudden loss of blood supply. After reviewing several large epidemiological studies, clinical trial and in-market data, EMA’s Pharmacovigilance Risk Assessment Committee has […]
The True Cost of “Optimal” Health
“I want to know I’m doing absolutely everything I can to preserve my health for as long as possible.” We hear this kind of thing a lot. People tell us they not only want to stay in good shape as they age, they also want to outlive their peers and age expectancies. Imagine you could […]
GLP-1 drugs are rewriting America’s food preferences, says IFF: ‘GLP-1s alter taste perception’
Eighty-five percent of US GLP-1 drug consumers report major changes in their food and beverage preferences after starting the medications, says a new report from ingredients giant IFF. And it’s not just about cutting down on junk food. “GLP-1s alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even mouthfeel, […]
Don’t Use Mounjaro As A Way To Get Skinny: Dr Alexandra Sowa, ‘The Ozempic Revolution’
An obesity and internal medicine specialist based in New York, Dr Alexandra Sowa has been researching and practising obesity medicine for about a decade now. Her new book, titled The Ozempic Revolution, is the first comprehensive user guide to GLP-1s—from the science and pop culture resonances of weight loss drugs and detailed guides to optimising […]
GLP-1 Receptor Agonist Exposure Linked to Neovascular AMD in Patients With Diabetes
FRIDAY, June 6, 2025 — For patients with diabetes, exposure to glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with an increased risk for incident neovascular age-related macular degeneration (nAMD) development, according to a…
Is Novo Nordisk’s Next Generation Obesity Pipeline a Game Changer?
Novo Nordisk NVO has seen strong momentum in recent years, driven by the commercial success of its blockbuster semaglutide products, Wegovy (obesity) and Ozempic (diabetes). Building upon this success, NVO is developing several next-generation candidates in its pipeline, especially targeting the lucrative U.S. market. The most advanced candidate in Novo Nordisk’s pipeline is CagriSema, a […]
EMA considers serious eye condition a ‘very rare’ side effect of semaglutide
The European Medicines Agency said Friday that the product information for Novo Nordisk’s Ozempic and Wegovy should be updated to list a serious eye condition as a “very rare” side effect. A
The ‘golden dose’ of Mounjaro that experts warn could be deadly – as slimmers rave about it saving money
A GROWING number of slimmers are trying to squeeze extra jabs out of empty Mounjaro pens in a risky bid to cut costs. The weight-loss injections, which can cost hundreds of pounds a month, are designed to deliver a fixed amount once a week, typically over four weeks. GettyExperts have warned against trying to get […]